Clinical Trial Update: SN514-066b Enzyme in Deep Partial Thickness Burns [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial evaluating the enzyme SN514-066b for deep partial-thickness burn injuries is currently enrolling by invitation, with SERDA bv as sponsor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burn Injury

Drugs mentioned

• SN514-066b

Snippet

Sponsor: SERDA bv | Conditions: Burn Injury | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION